首页> 外文会议>ICMSI;International conference of molecular simulations and applied informatics technologies >Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors
【24h】

Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors

机译:基于结构的虚拟筛选,用于鉴定新型11β-HSD1抑制剂

获取原文

摘要

Structure-based pharmacophore models were built by using LigandScout and used for virtual screening of the SPECS database to identify new potential 11β-HSD1 inhibitors. As a refinement of the results obtained from virtual 3D pharmacophore screening, the best fitting virtual hits were subjected to docking study. The resulting compounds were tested in an enzyme assay and revealed several compounds with novel scaffolds that show sub-micromolar activity and high selectivity for 11β-HSD1 against 11β-HSD2.
机译:通过使用LigandScout构建基于结构的药效团模型,并将其用于SPECS数据库的虚拟筛选,以识别新的潜在11β-HSD1抑制剂。为了完善从虚拟3D药效团筛选获得的结果,对最合适的虚拟匹配进行了对接研究。所得化合物在酶测定法中进行了测试,发现了几种具有新型支架的化合物,这些支架显示出亚微摩尔活性,并且对11β-HSD1具有相对于11β-HSD2的高选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号